series-a
Stage
1
Investors
About
KSK Diagnostics is a medical device company developing a novel diagnostic platform for the early detection of cancer. Their technology focuses on isolating and analyzing circulating tumor cells (CTCs) from blood samples.
Explore KSK Diagnostics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.